drug
tofacitinib ER
Marketedupdated 3mo agoby Sinotherapeutics Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval120 co-mentions · 60 sources
- drugXELJANZ111 co-mentions · 60 sources
- drugXELJANZ XR111 co-mentions · 60 sources
- drugTOFACITINIB CITRATE111 co-mentions · 60 sources
- tagSmall Molecule60 co-mentions · 60 sources
- drugtofacitinib60 co-mentions · 60 sources
- drugtofacitinib citrate ER60 co-mentions · 60 sources
- companyAjanta Pharma Ltd7 co-mentions · 7 sources
indications
investigational
IBD (Crohn's + UC)Rheumatoid Arthritis
all catalysts(0)
nothing on the calendar yet
Trials studying tofacitinib ER
- phase4A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- —Korean Post-marketing Surveillance for Xeljanz XR
- phase3Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
- —Effects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT Project
- phase2Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
- phase2A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitis
- phase3Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis
- —Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2m ago
Found something off?
comments(0)
5-min edit window · permanent after that